Reumacon (CPH82) showed similar x-ray progression and clinical effects as methotrexate in a two year comparative study on patients with early rheumatoid arthritis

Scandinavian Journal of Rheumatology

Volumn 32, Issue 2, 2003, Pages 83-88

  Svensson, Björn ^a,c   Pettersson, Holger ^b  

^a Rheumatology Section   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c NONE   (Sweden)

Author keywords

CPH82; Early rheumatoid arthritis; Larsen score; Methotrexate; Randomized trial; Reumacon; X ray progression

Indexed keywords

CPH 82; METHOTREXATE;

ADULT; ARTICLE; BONE EROSION; CLINICAL TRIAL; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SAFETY; DRUG TOLERABILITY; FACE EDEMA; FEMALE; GENERAL CONDITION IMPROVEMENT; HUMAN; LEUKOPENIA; LIVER TOXICITY; LUNG ALVEOLITIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PRURITUS; RHEUMATOID ARTHRITIS; THROMBOCYTOPENIA; TREATMENT OUTCOME; X RAY ANALYSIS;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; ARTHROGRAPHY; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FEMALE; GLYCOSIDES; HUMANS; JOINTS; LIGNANS; MALE; METHOTREXATE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0037258334     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/03009740310000085     Document Type: Article

References (18)

1. Larsen A, Petersson I, Svensson B. Podophyllum derivatives (CPH82) compared with placebo in the treatment of rheumatoid arthritis. Br J Rheumatol 1989;28:124-7.
2. Lerndal T, Svensson B. A clinical study of CPH82 vs. methotrexate in early rheumatoid arthritis. Rheumatology 2000;39;3:316-20.
3. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of Rheumatoid Arthritis. Arthritis Rheum 1988;31:315-24.
4. Larsen A, Dale K. Standardised Radiological Evaluation of Rheumatoid Arthritis in Therapeutic Trials. Editors: Dumonde DC, Jasani MK. The Recognition of Anti-Rheumatic Drugs. MTP Press Limited 1978:285-92.
5. Wollheim FA, Pettersson H, Saxne T, Sjöblom KG. Radiographic assessment in relation to clinical and biochemical variables in rheumatoid arthritis. Scand J Rheumatol 1988;17:445-53.
6. EULAR Handbook Of Clinical Assessments in Rheumatoid Arthritis 2000:Ed. Piet LCM van Riel. Published by Van Zuiden Communications B.V.
7. Ritchie DM, Boyle JA, McInnes JM, et al. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 1968;147:393-406.
8. Ekdahl C, Eberhardt K, Andersson SI, Svensson B. Assessing disability in patients with rheumatoid arthritis. Scand J Rheumatol 1988;17:263-71.
9. Fries JF, Spitz PW, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-45.
10. Van der Heijde DMFM, van't Hof MA, van Riel PLCM, van de Putte LBA. Development of a disease activity score based on judgement in clinical practice by rheumatologists. J Rheumatol 1993;20:579-81.
11. Van Gestel AM, Prevoo MLL, van't Hof MA, et al. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Arthritis Rheum 1996;39:34-40.
12. Prevoo ML, van Gestel AM, van T Hof MA, van Rijswijk MH, van der Putte LB, van Riel PL. Remission in a prospective study of patients with rheumatoid arthritis. American Rheumatism Association preliminary remission criteria in relation to the disease activity score. Br J Rheumatol 1996;35:1101-5.
13. Dougados M, Combe B, Cantagrel A, et al. Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components. Ann Rheum Dis 1999;58:220-5.
14. Möttönen T, Paimela L, Leirisalo-Repo M, Kautiainen H, Ilonen J, Hannonen P. Only high disease activity and positive rheumatoid factor indicate poor prognosis in patients with early rheumatoid arthritis treated with "sawtooth" strategy. Ann Rheum Dis 1998;57:533-9.
15. Pincus T, Sokka T. How can the risk of long-term consequences of RA be reduced? Best Practice and Research. Clin Rheumatol 2001;15:139-70.
16. Sharp JT, Strand V, Leung H, Hurley F, Loew-Friedrich I. Treatment with Leflunomide slows radiographic progression of rheumatoid arthritis: results from three randomized controlled trials of Leflunomide in patients with active rheumatoid arthritis. Arthritis Rheum 2000;43:495-505.
17. Borg G, Allander E, Lund B, et al. Auranofin improves outcome in early rheumatoid arthritis. Results from a 2-year double blind, placebo controlled study. J Rheumatol 1988;15:1747-54.
18. ACR Subcommittee on RA Guidelines: Guidelines for the Management of Rheumatoid Arthritis. Arthritis Rheum 2002;46:328-46.